Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Anthropic is scrambling to contain the leak, but the AI coding agent is spreading far and wide and being picked apart.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results